August 17, 2012

Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation


Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177
.   .   

This randomized controlled trial assessed whether sirolimus would prevent further skin cancers in patients who have had a first squamous-cell skin cancer post-renal transplant. Patients were either continued on their calcineurin inhibitor or were switched to sirolimus. Freedom from a second skin cancer was longer with sirolimus. Switching to sirolimus earlier after a fist skin cancer may be better than waiting longer.

Renal Transplantation

Tags: , , , ,